Clinical Trial Results: Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 3]

View source ↗

Summary

Phase 3 trial results comparing REGN 2810 to platinum-based chemotherapy in metastatic non-small cell lung cancer have been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• REGN 2810

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Carcinoma，Non-Small-Cell Lung, Lung Carcinomas, Non-Small-Cell | Phase 3 | Status: COMPLETED | Results posted: 2026-06-25